You have no items in your shopping cart.
All Products
Recombinant Human TFF2 (C-6His) [orb2994883]Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 13 KDa. Observed: 19 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Recombinant Human FAH (C-6His) [orb2994884]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 47.4 KDa. Observed: 43 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human QDPR (C-6His) [orb2994885]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 26.8 KDa. Observed: 29 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human LGALS3 (C-6His) [orb2994886]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 27.2 KDa. Observed: 35 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human VIP36 (C-6His) [orb2994887]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 32.7 KDa. Observed: 33 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human PCDH1 (C-6His) [orb2994888]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 87.3 KDa. Observed: 120 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human RRM2 (C-6His) [orb2994889]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45.9 KDa. Observed: 47 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human TNF RII (C-mFc) [orb2994890]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.44 KDa. Observed: 60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.6&31.3 KDa. Observed: 14&33 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Recombinant Cynomolgus PD-L2 (C-6His) [orb2994892]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.4 KDa. Observed: 30-40 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg